Product Details
Taro-Clarithromycin
Clarithromycin250 mg/5 mL
Suspension
DIN/PIN/NPN
02390450
Manufacturer
Taro Pharmaceuticals Inc.
Formulary Listing Date
2013-01-29
Unit Price
0.4685
Amount MOH Pays
0.4685
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Antibiotics, Erythromycins (08:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.
ATC Code
J01FA09
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02390450 | Taro-Clarithromycin | 0.4685 | 0.4685 |
| 02244641 | Biaxin | 0.6466 | 0.4685 |